dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate

C62H78BBrK2N12O9 — CID 160744924

About dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate

dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate (PubChem CID 160744924) has the molecular formula C62H78BBrK2N12O9 and a molecular weight of 1304.29 g/mol. Its IUPAC name is dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate.

Molecular Properties

• Compound Name: dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate
• PubChem CID: 160744924
• Molecular Formula: C62H78BBrK2N12O9
• Molecular Weight: 1304.29 g/mol
• Exact Mass: 1302.46
• IUPAC Name: dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate
• SMILES: C.CC1C(=O)N(C)Cc2c(Br)nc(C3CCOCC3)n21.Cc1cc2c(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4C)cccc2nc1-c1cnn(C)c1.Cc1cc2c(B3OC(C)(C)C(C)(C)O3)cccc2nc1-c1cnn(C)c1.O=CO[O-].[H-].[K+].[K+]
• InChI: InChI=1S/C27H30N6O2.C20H24BN3O2.C13H18BrN3O2.CH2O3.CH4.2K.H/c1-16-12-21-20(6-5-7-22(21)29-24(16)19-13-28-32(4)14-19)25-23-15-31(3)27(34)17(2)33(23)26(30-25)18-8-10-35-11-9-18;1-13-10-15-16(21-25-19(2,3)20(4,5)26-21)8-7-9-17(15)23-18(13)14-11-22-24(6)12-14;1-8-13(18)16(2)7-10-11(14)15-12(17(8)10)9-3-5-19-6-4-9;2-1-4-3;;;;/h5-7,12-14,17-18H,8-11,15H2,1-4H3;7-12H,1-6H3;8-9H,3-7H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
• InChIKey: KBDCXJRTUUPKMC-UHFFFAOYSA-M
• XLogP: 2.74
• TPSA: 223.96 Ų
• H-Bond Acceptors: 19
• Rotatable Bonds: 7
• Heavy Atoms: 87
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	1304.29
LogP ≤ 5	2.74
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	19

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate?

The IUPAC name of dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate (CID 160744924) is dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate.

What is the SMILES notation for dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate?

The canonical SMILES for dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate is C.CC1C(=O)N(C)Cc2c(Br)nc(C3CCOCC3)n21.Cc1cc2c(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4C)cccc2nc1-c1cnn(C)c1.Cc1cc2c(B3OC(C)(C)C(C)(C)O3)cccc2nc1-c1cnn(C)c1.O=CO[O-].[H-].[K+].[K+].

What is the InChIKey of dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate?

The InChIKey is KBDCXJRTUUPKMC-UHFFFAOYSA-M. The full InChI is InChI=1S/C27H30N6O2.C20H24BN3O2.C13H18BrN3O2.CH2O3.CH4.2K.H/c1-16-12-21-20(6-5-7-22(21)29-24(16)19-13-28-32(4)14-19)25-23-15-31(3)27(34)17(2)33(23)26(30-25)18-8-10-35-11-9-18;1-13-10-15-16(21-25-19(2,3)20(4,5)26-21)8-7-9-17(15)23-18(13)14-11-22-24(6)12-14;1-8-13(18)16(2)7-10-11(14)15-12(17(8)10)9-3-5-19-6-4-9;2-1-4-3;;;;/h5-7,12-14,17-18H,8-11,15H2,1-4H3;7-12H,1-6H3;8-9H,3-7H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1.

What are the key properties of dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate?

dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate has a molecular weight of 1304.29 g/mol, XLogP of 2.74, 7 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.

Where does this data come from?

All data for dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-methyl-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;oxido formate is sourced from PubChem (CID 160744924), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).